Netherlands· NL-851cb6b21453
Flurazepam HCl Aurobindo 15 mg, capsules
A flurazepam product containing flurazepam monohydrochloride, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Flurazepam is registered in 11 of 19 countries.
Countries holding a registration under ATC N05CD01 (flurazepam), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
Flurazepam · ATC N05CD01
11 / 19 countries
- Belgiumprice
- Canada
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of flurazepam costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.14 in Spain to $1.13 in Switzerland — a ×7.9 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Flurazepam · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.13
- ES Spain$0.14
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FLURAZEPAM MONOHYDROCHLORIDE
- Manufacturer
- Aurobindo Pharma B.V.
- Country
- Netherlands (NL)
- ATC code
- N05CD01
- ATC class
- Flurazepam
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- July 14, 2026
Packs & prices · 1
- cbg_meb_id21481=56480
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
209 interactions on record for flurazepam.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flurazepam · interactions on record
209 records
- 4 severe
- 107 moderate
- 22 minor
- 32 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
44 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Flurazepam in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayDalmadormMeda
- BelgiumStaurodorm 27.42 mgViatris Healthcare
- GermanyDalmadormViatris Healthcare Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Germany · Dalmadorm
- Spain · Dormodor
- United Kingdom (Northern Ireland) · Dalmane
- Croatia · Fluzepam
- Ireland · Dalmane
- Italy · Dalmadorm, Felison
- Portugal · Dalmadorm
- Slovenia · Fluzepam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bae075ee-b224-441d-8f0b-b4ff44596aef GET /v1/drugs/bae075ee-b224-441d-8f0b-b4ff44596aef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h56480_smpc.pdf",
"strength": null,
"atc_label": "Flurazepam",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg21481",
"excipients": [
"BRILJANTZWART BN (E 151)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"ERYTHROSINE (E 127)",
"GELATINE (E 441)",
"IJZEROXIDE ROOD (E 172)",
"IJZEROXIDE ZWART (E 172)",
"LACTOSE 1-WATER",
"LECITHINE, SOYA (E 322)",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMZETMEELGLYCOLAAT",
"POVIDON K 90 (E 1201)",
"RODE INKT",
"SCHELLAK (E 904)",
"SILICIUMDIOXIDE (E 551)",
"SILICONEN ANTISCHUIM DC 1510",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"FLURAZEPAM MONOHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h21481.pdf",
"authorised_at": "1997/07/07",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "21481=56480",
"additional_monitoring": "N"
}See everything about flurazepam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.